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ABSTRACT
Background: In the late 1960s, the first isolates ofAeromonas were recovered from human specimens.
Presently, there is sufficient evidence to suggest that the different isolates of the genus Aeromonas
are human pathogens. The most frequent site of infection is the digestive tract, although extra-
intestinal infection also occurs. In those cases involving septicemia, most infections occur in indi-
viduals with underlying diseases. This report presents the case of a pregnant woman with no
underlying disease or signs of immunodeficiency who developed A. kydropkila septicemia at 24
weeks gestation.
Case: A 20-year-old pregnant woman was admitted with a history of 10 days of fever, chills,
and diaphoresis. Three days before her hospitalization, she noted jaundice and choluria. Her liver
was enlarged and her liver function tests were abnormal, with a moderate elevation of serum
aminotransferases and direct serum bilirubin and a high serum alkaline phosphatase. Her blood
and bone-marrow cultures revealed A. kydropkila. She was treated with parenteral ceftriaxone. She
experienced a complete remission ofher symptoms and laboratory abnormalities after therapy. The
remainder ofthe pregnancywas normal. At 39.2 weeks gestation, she delivered ahealthy male infant.
Conclusion: An association was noted between pregnancy and A. kydrophila septicemia in a
woman without immunodeficiency or underlying disease, possibly indicating another infectious
complication in pregnancy. (C) 1996 Wiley-Liss, Inc.
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embers ofthe genus Aeromonas are gram-nega-
tive rods that belong to the family Vibriona-
ceae. They are oxidase-positive, facultative anaer-
obes with large zones of hemolysis around colonies
on blood agar that ferment carbohydrates. ’z
Aeromonas was isolated in human feces for the
first time in 1937. Not until 1980 was it recognized
as a pathogenic bacteria causing gastrointestinal dis-
eases in human beings. The spectrum of intestinal
diseases caused by Aeromonas ranges from acute,
self-limited gastroenteritis of moderate intensity to
chronic diarrhea that can persist for weeks or
months. With lesser frequency, aeromonads have
been associated with extra-intestinal infections, re-
sulting in peritonitis, osteomyelitis, skin and soft-
tissue infections, meningitis, endocarditis, and sep-
ticemia.I,4-6
It has been suggested that patients who have
immunosuppression or malignant diseases are more
easily infected with aeromonads, although normal,
healthy individuals may become infected as well.
In cases ofAeromonas septicemia, many of the infec-
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tions occur in individuals with neoplastic diseases,
while septicemia in patients without predisposing
conditions is rare.
A case of a pregnant woman without previous or
concomitant disease, who developed an A. hy-
drophila septicemia at 24 weeks gestation is pre-
sented. A brief review of the literature on the associ-
ation and incidence of Aeromonas infections and
pregnancy is also presented.
CASE REPORT
A 20-year-old primigravida at 24 weeks of gestation
was admitted to the National Institute of Perinatol-
ogy with a history of 10 days of fever, chills, diapho-
resis, asthenia, and adynamia. Three days before
her hospitalization, she noted choluria and jaundice
and complained of a cough and pharyngeal pain.
On her admission, she was agitated, and tachycardic
with mental obtundation. She had dry oral mucosa,
decreased skin turgor, and generalized jaundice.
Her temperature was 38.5C. Her examination re-
vealed right upper-quandrant pain, an enlarged
liver, and a pregnant uterus. A complete blood count
revealed slight normochromic/normocytic anemia
and a leukocyte count of 5,300/I,1 with 22% bands.
Her liver function tests were abnormal, with a mod-
erate elevation of serum aminotransferases (aspar-
tate aminotransferase of 66 u/1 and alanine amino-
transferase of 52 u/l), an increase in direct serum
bilirubin to 3.8 mg/dl, and a high serum alkaline
phosphatase of 1,628 u/1. An abdominal ultrasound
showed a normal biliary tract and an enlarged liver.
A viable fetus with a gestational age of 18-20 weeks
was observed. The discrepancy between the pa-
tient’s reported gestational age and the ultrasound
finding was attributable to her irrregular menstrual
cycle, making the true gestational age of the fe-
tus uncertain.
The clinical picture was compatible with a sepsis
syndrome. She was treated with parenteral ceftriax-
one. On the 4th day of hospitalization, she became
less febrile, and her blood and bone-marrow cul-
tures revealed A. hydrophila. The bone-marrow cul-
ture was initially done to rule out typhoid fever. A
stool culture was not done because the patient had
no gastrointestinal symptoms. She experienced a
complete remission of the signs and symptoms of
sepsis and a normalization of her laboratory tests
after therapy.
The serologic studies against hepatitis virus A,
B, and C as well as anti-HIV were negative. The
A. hydrophila isolated was resistant to gentamycin.
The remainder of her pregnancy was normal. At
39.2 weeks, she reentered the hospital and deliv-
ered a healthy male. The histopathologic study of
the placenta was normal.
DISCUSSION
In the last 2 decades, the genus Aeromonas has been
increasingly recognized as a human pathogen. In
the early 1980s, on the basis of biochemical charac-
teristics, 4 phenotypes of Aeromonas were recog-
nized: A. hydrophila, A. sobria, A. caviae, and A. veto-
nil Because of the marked differences in the
polynucleotide sequences in each of these pheno-
types, a new classification based on DNA-DNA
reassociation kinetics was proposed: the hybridiza-
tion group (HG). For most institutions, the identifi-
cation of Aeromonas isolates within the HG is im-
practical because of the technical time required and
the costs of reagents and equipment. A feasible
alternative is to identify aeromonads within the
phenotypes.
Initially, aeromonads were identified as patho-
genic in cold-blooded animals. In 1968, von Graeve-
nitz and Mensch1 reported the first series of Aero-
monas isolates from human specimens. Of the 30
cases reported, 14 were of gastrointestinal origin.
In 19 patients, the isolates were mixed with other
bacteria. In 2 of them, both with hepatic cirrhosis,
the isolation was from a blood culture.1 Presently,
there appears to be a consensus that aeromonads
cause gastrointestinal disease. In addition to their
pathogenic role, aeromonads have been found in
the feces of so-called asymptomatic carriers.
In 1988, the State of California established that
an infection with Aeromonas was an obligatory re-
portable disease.1 In California, the annual inci-
dence ofAeromonas infection was 10.6 cases/million
inhabitants. In 1 year, Aeromonas was isolated in
the feces of 178 patients; in 19, from soft-tissue
infections; in 11, from blood cultures; in 5, from bile;
and in 12, from various other specimens including
urine, sputum, eye, and placenta. Ninety percent
of the patients with Aeromonas isolated from their
feces also had gastrointestinal symptoms.
1
After the digestive tract, the most frequent sites
of aeromonad infections are the skin and soft tis-
sues. The majority of these cases are associated
with trauma in aquatic environments and contami-
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nation of injuries, lz-1 The spectrum of these infec-
tions include cellulitis, gas gangrene, myonecrosis,
fulminant necrotizing infections, and osteomyelitis.
Voss et al. 15 recently reported a series of 28 patients
with musculoskeletal and soft-tissue Aeromonas in-
fections, 23 (82%) ofwhom had acute open or pene-
trating injuries. In 13 of these, the initial trauma
occurred in lake or river water. In the pathogenesis
of this type of infection, it has been suggested that
aeromonads produce hemolysins and cytotoxins
that serve as virulent factors. These intracellular
products may facilitate the tissue damage as well
as muscle lesions. 16
Septicemia due to Aeromonas is infrequent. Most
cases are sporadic and community acquired, al-
though nosocomial cases have been described.4’7’8
A. hydrophila and A. sobria have been implicated as
the species most frequently associated with septice-
mia.8’7’8 Aeromoas septicemia is most likely to oc-
cur in patients who have immunocompromised or
some underlying disease such as a malignancy, liver
cirrhosis, or diabetes mellitus and perhaps in the
elderly as a result of a decline in immune
functions.7,8,7,8
Few cases of septicemia caused by Aeromonas
have been described in patients without immuno-
deficiency. In the patient presented here, there was
no underlying disease or history of immunodeficie-
ncy. In a series of 24 patients with Aeromonas bac-
teremia, only I was reported as not having a neoplas-
tic disease. In another study of 16 patients with
septicemia, 8 had hematologic disorders and 6 had
severe underlying illnesses, while only 2 were ap-
parently healthy. Thirteen patients with Aeromonas
septicemia were reported from Australia in the
years between 1983 and 1987. Chronic illnesses
were present in 10 of these. Of the 3 remain-
ing patients, 2 presented with cholangitis and the
third, an otherwise healthy 20-year-old male, devel-
oped fever 4 days after an umcomplicated tonsi-
lectomy.
1
In all cases reported in the literature, the mortal-
ity was significanly associated with the severity of
the underlying disease. In the epidemiologic stud-
ies of Aeromonas infection reported from the State
of California, the mortality rate was 2.3%, with 5
deaths occurring in hospitalized patients with se-
vere medical disorders. Three of the deaths oc-
curred among 11 patients who developed septice-
mia, giving a mortality rate for this group of 27.3%.
11
The mortality rate with Aeromonas septicemia re-
ported in other series of cases ranged from 27 to
56%.7,
In some cases ofAeromonas septicemia, the origin
of the infection is evident, e.g., from an abscess,
cellulitis, infected ulcer, or empyema. A minority
of cases developed septicemia or skin lesions com-
patible with ecthyma gangrenosum. 7’8’8 In the case
reported here, the principal manifestation was jaun-
dice, an infrequent sign in this type of infection.
Harris et al., in their study of 24 patients, identified
only 1 patient with jaundice. In the series reported
by Vilasecal-Momplet et al., only 2 of 16 patients
presented with jaundice secondary to cholangitis.
In these patients, an infection of the intrahepatic
biliary tract was the origin of the septicemia. The
moderate alterations in the liver function tests pre-
sented by our patient and the correction of these
laboratory abnormalities after therapy suggest that
the liver function abnormalities resulted from cho-
lestasis secondary to sepsis.
In a review of the medical literature usingMED-
LINE CD-ROMM and Index Medicus from 1970 to
1994, we found no report of an association between
Aeromonas septicemia and pregnancy. However,
there were reports of the isolation of Aeromonas in
septic abortion material and placenta.
1 In an ab-
stract of an infectious diseases conference just
case was reported of a pregnant woman who died
as a result of a septic abortion in whom A. hydrophila
was isolated from a blood culture.
9
The vulnerability of pregnant women to infec-
tions depends on many host factors, including past
and present immunologic status, hormonal and he-
matologic changes occurring during pregnancy, and
perhaps dietary habits. Some altered immune re-
sponses during pregnancy involve a decrease in spe-
cific antibody titers, a decrease in total T-lympho-
cytes, and a decrease in helper-suppressor ratios, as
well as a decrease in the chemotactic and phagocytic
properties of granulocytes,z
In the case reported here, the origin of the sepsis
is still unknown. In the majority of the septicemia
cases we reviewed, the origin was considered to be
endogenous, principally from the patient’s diges-
tive tract.
Aeromonas species are usually susceptible in vitro
to third-generation cephalosporins, quinolones, and
aminoglycosides, as well to the new [3-1actam antibi-
otics such as aztreonam and imipenem,z
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